Intracellular antibodies: development and therapeutic potential

By Richardson J.H.   Marasco W.A.  

Trends in Biotechnology, Vol. 13, Iss. 8, 1995-08 ,pp. : 306-310

Elsevier

Access to resources Recommend Favorite

Hla-Dr/dq Transgenic, class II deficient mice as a novel model to select for HSP T cell epitopes with immunotherapeutic or preventative vaccine potential.

By Geluk A.  

Biotherapy, Vol. 10, Iss. 3, 1998-01 ,pp. : 191-196

Springer Publishing Company

Access to resources Recommend Favorite

Potential therapeutic use of antibodies directed towards HuIFN-

By Froyen G.   Billiau A.  

Biotherapy, Vol. 10, Iss. 1, 1997-01 ,pp. : 49-57

Springer Publishing Company

Access to resources Recommend Favorite

Potential side effects of insect-resistant transgenic plants on arthropod natural enemies

By Schuler T.H.   Poppy G.M.   Kerry B.R.   Denholm I.  

Trends in Biotechnology, Vol. 17, Iss. 5, 1999-05 ,pp. : 210-216

Elsevier

Access to resources Recommend Favorite

The genetic reconstruction of BCG as a new immunotherapeutic tool

By O'Donnell M.A.  

Trends in Biotechnology, Vol. 15, Iss. 12, 1997-12 ,pp. : 512-517

Elsevier

Access to resources Recommend Favorite